Search Articles — Sudonull

https://sudonull.com/economy-of-lunar-rocket-fuel-analysis-model

Breakdown of the economic model for fuel production from lunar ice. Key parameters G and 𝜙 for competitiveness on LEO and GEO. For space systems developers — calculations and TEA.

https://sudonull.com/nasa-lunar-base-for-20-billion-stages-and-technologies

NASA is building a base on the Moon for $20 billion as part of Artemis. Three stages, abandonment of Gateway, international participation. Details of infrastructure and missions for developers of space systems.

https://sudonull.com/robot-luna-limx-33-dof-nvidia-orin

Humanoid Luna from LimX Dynamics: 33 degrees of freedom, Visual SLAM, 157 TOPS on Orin NX. Tech specs for devs, comparison with Oli. Study navigation and ROS 2.

https://sudonull.com/lunar-fire-why-gravity-is-more-dangerous-than-weightlessness

NASA is preparing the FM2 mission to study combustion in lunar gravity. Learn why fire on the Moon may be more aggressive than on the ISS and how this will affect the Artemis program.

https://sudonull.com/china-s-lunar-ship-crewed-mission-by-2030

China is actively developing the crewed Mengzhou spacecraft for a Moon landing before 2030. Learn how this will shift the balance of power in the space race and what resources are at stake.

https://ymaho.com/tarlatamab-imdelltra-approved-by-fda-new-standard-for-small-cell-lung-cancer

FDA fully approved tarlatamab for second-line therapy of small cell lung cancer after the DeLLphi-304 study. Learn about the breakthrough in treatment and new options for patients.

https://ymaho.com/lung-cancer-drug-lurbinectedin-approved-in-europe

Europe approved the world's first Lurbinectedin drug with immunotherapy for aggressive lung cancer. 46% reduction in risk of death. Learn about the breakthrough and forecasts.

https://ymaho.com/new-drug-combination-for-lung-cancer-therapy-european-approval

European Commission approved Zepzelca and atezolizumab combination for aggressive lung cancer. 27% reduction in risk of death. Learn details about the new standard of therapy.

https://ymaho.com/mechanism-of-lung-cell-adaptation-to-tobacco-smoke-the-role-of-nrf2

Nature study: chronic smoke exposure causes mitochondrial fragmentation and NRF2 activation. How does this lead to cancer and why are antioxidants dangerous? Read.

https://lrivo.com/diego-luna-mls-form-boosts-us-world-cup-spot-bid

Diego Luna's goal & assists for RSL strengthen his US World Cup roster case. Analysis of MLS weekend including Crew struggles & Messi's impact.

https://ymaho.com/first-mrna-vaccine-against-lung-cancer-from-biontech

BioNTech's personalized mRNA therapy against NSCLC is on the way. The vaccine reduces the risk of melanoma recurrence by 49%. Learn about the future of personalized oncology.

https://ymaho.com/autonomous-robotic-lung-transplantation-star-breakthrough

Robot STAR performed lung transplantation with superhuman precision. Learn how this will change the surgery market and what opportunities it opens. Read the analysis!

https://lrivo.com/klopp-real-madrid-plans-lunin-sale-260m-signings

Reports detail Jurgen Klopp's potential demands as Real Madrid manager, including selling Lunin and major transfers. Get the latest speculation.

https://ymaho.com/orphan-status-of-combination-for-lung-cancer-treatment-new-ema-approach

European Commission granted orphan status to Zepzelca combination with atezolizumab for lung cancer. Learn how EMA reform changes rules for SCLC and who benefits from this decision. Detailed analysis.

https://ymaho.com/adc-drugs-against-resistant-small-cell-lung-cancer-breakthrough-2026

New class of ADC drugs targets DLL3 and B7-H3, overcoming SCLC resistance. Analysis of efficacy, toxicity, and treatment prospects. Read more.